超敏反应对硬膜外类固醇注射预后的预测价值:一种表型特征?前瞻性队列研究
该前瞻性队列研究探讨超敏反应(HR)与硬膜外类固醇注射(ESI)预后的关联。HR分为免疫相关和非免疫相关,并按数量分组。主要结局为术后1个月平均腿痛评分降低。结果显示非免疫相关HR与部分ESI结局指标呈负相关,高非免疫相关HR组腿痛改善更差。
要点
- 非免疫相关超敏反应数量与ESI后腿痛改善呈负相关。
- 高非免疫相关HR组腿痛平均降低-0.2±2.3,低组1.7±2.5(p=0.002)。
- 非免疫相关HR低、中、高组 categorical 阳性结局分别为51%、35%、12%(p=0.007)。
核心结论
- 非免疫相关超敏反应与部分硬膜外类固醇注射结局指标呈负相关。
研究设计与样本
- 前瞻性队列研究,纳入接受硬膜外类固醇注射的患者,超敏反应分为免疫相关和非免疫相关,并按数量分组:0为低,1或2为中等,≥3为高。
主要发现
- 高总HR组(n=24)平均腿痛降低0.1±2.7,低总HR组(n=61)降低1.8±2.1(p=0.025),中等总HR组(n=52)降低1.6±3.1(p=0.060)。
- 非免疫相关HR低、中、高组平均腿痛降低分别为1.7±2.5、1.6±3.0、-0.2±2.3(p=0.002)。
- 非免疫相关HR低、中、高组 categorical 阳性结局比例分别为51%、35%、12%(p=0.007)。
- 按免疫相关HR分层时,结局无差异。
临床怎么用
- 对于计划接受硬膜外类固醇注射的患者,评估非免疫相关超敏反应数量可能有助于预测预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies have found that diffuse pain, indicative of central sensitization, portends poor interventional outcomes. Multiple chemical sensitivities are associated with signs of central sensitization. We sought to prospectively determine whether hypersensitivity reactions (HR) were associated with epidural steroid injection (ESI) outcomes. METHODS: HR were classified as immune-related or non-immune-related and categorized by number (0=low, 1 or 2=intermediate, ≥3=high). The primary outcome measure was mean reduction in average leg pain score 1 month post-procedure. A positive outcome was defined as a two-point or greater decrease in average leg pain accompanied by satisfaction 1 month post-procedure. RESULTS: The mean number of immune-mediated and non-immune-mediated HR were 0.6±1.2 and 0.8±1.4, respectively. Individuals in the high (n=24) total HR group had a mean reduction in average leg pain of 0.1±2.7, compared with those in the low (n=61; 1.8±2.1, p=0.025) and intermediate groups (n=52; 1.6±3.1, p=0.060). For back pain and categorical successful outcome, those with fewer HR experienced greater benefit. There were no differences in outcomes when patients were stratified by immune-related HR. Among participants in the low, intermediate and high non-immune-mediated HR groups, the mean reductions in average leg pain scores were 1.7±2.5, 1.6±3.0, and -0.2±2.3, respectively (p = 0.002). 51%, 35%, and 12% of people with low, intermediate and high numbers of non-immune-mediated HR experienced a positive categorical outcome, respectively (p=0.007). CONCLUSIONS: Non-immune-related HR were inversely correlated with some ESI outcome measures.
引用
- Cohen SP, Doshi TL, Dawson TC, et al. Prognostic value of hypersensitivity reactions on epidural steroid injection outcomes: a phenotypic signature? A prospective cohort study. Reg Anesth Pain Med. 2019. PMID: 30962251. doi:10.1136/rapm-2018-100276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。